# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Dec 5, 2023

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2023-12-05
- Accepted by EDGAR: Dec 5, 2023, 17:16 ET
- Period: 2023-12-05
- Accession: 0001628280-23-040776
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000162828023040776/arwr-20231205.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000162828023040776/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000162828023040776/arwr-20231205.htm

Filed Dec 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-040776. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.